For its fifth edition, the EFFERVESCENCE Start-up Pitch Competition will fuel the rise of Canadian start-ups whose innovations aim to transform the field of life sciences and health technologies (LSHT).
The 10 start-ups selected as finalists will get the opportunity to present their pitch before the EFFERVESCENCE participants at marché Bonsecours in Montreal. The pitches will be judged by a panel of judges, each of whom is a recognized expert or investor in the field of LSHT
What are the Categories?
participating start-ups will be grouped into two categories:
Medical Technology & Digital Health.
Biopharmaceutical & Biotechnology
Eligibility Criteria EFFERVESCENCE Start-up Pitch Competition
- The goal of the EFFERVESCENCE Start-up Pitch Competition is to showcase the most transformative innovations developed by Canadian startups seeking to make breakthroughs in the SVTS community, which which includes the following sectors:
- Biopharmaceuticals;
- Biotechnology (human and animal health)
- Medical Technologies;
- Digital Health.
To be eligible, the applicant start-up must:
- Be incorporated and have its head office in Canada;
- Be at an early stage of development;
- Be based on an innovative product or service;
- Demonstrate strong growth potential;
- Not have received a dilutive investment of more than CAD $3 million
Access more funding and grants opportunities for Startups
Prizes
The winning teams will be offered cash prizes to contribute to their transformative innovation momentum, including (but not limited to!):
- $10,000 prize sponsored by adMare BioInnovations;
- $10,000 prize sponsored by le Fonds de solidarité FTQ.
Other cash prizes to be announced shortly
Application
Note: Last day to apply for the Startup Pitch Competition is 10th February, 2025